Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Majoor

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Acta Orthopaedica|May 1, 2019
Pain in fibrous dysplasia: relationship with anatomical and clinical featuresBas C J Majoor, Eva Traunmueller, Werner Maurer-Ertl, et al.
Clinical Orthopaedics and Related Research|March 30, 2016
What Is the Role of Allogeneic Cortical Strut Grafts in the Treatment of Fibrous Dysplasia of the Proximal Femur?Bastiaan C J Majoor, Marleen J M Peeters-Boef, Michiel A J van de Sande, et al.
Lung|June 29, 2013
Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal studyMyrthe P P van Herk-Sukel, Sumitra Shantakumar, Fernie J A Penning-van Beest, et al.
Chest|October 18, 2019
Corticosteroid Withdrawal-Induced Loss of Control in Mild to Moderate Asthma Is Independent of Classic Granulocyte ActivationLinsey E S de Groot, Marianne A van de Pol, Niki Fens, et al.
Orphanet Journal of Rare Diseases|April 29, 2017
Determinants of impaired quality of life in patients with fibrous dysplasiaBas C J Majoor, Cornelie D Andela, Jens Bruggemann, et al.
Allergy|December 28, 2020
Transcriptional changes in alveolar macrophages from adults with asthma after allergen challengeJack Yang, Brendon P Scicluna, Tjitske S R van Engelen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 29, 2015
Loss of asthma control and activation of coagulation and fibrinolysisM M S Sneeboer, N Fens, M A van de Pol, et al.
Expert Opinion on Drug Safety|May 25, 2021
The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heartA M Akkerman-Nijland, J E Möhlmann, O W Akkerman, et al.
Therapeutic Drug Monitoring|November 9, 2020
Quantitative Method for the Analysis of Ivacaftor, Hydroxymethyl Ivacaftor, Ivacaftor Carboxylate, Lumacaftor, and Tezacaftor in Plasma and Sputum Using Liquid Chromatography With Tandem Mass Spectrometry and Its Clinical ApplicabilitySteffie E M Vonk, Marloes van der Meer-Vos, Lieuwe D J Bos, et al.
Calcified Tissue International|December 2, 2021
Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's SyndromeM Hagelstein-Rotman, N M Appelman-Dijkstra, A M Boyce, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Acta Orthopaedica|May 1, 2019
Pain in fibrous dysplasia: relationship with anatomical and clinical featuresBas C J Majoor, Eva Traunmueller, Werner Maurer-Ertl, et al.
Clinical Orthopaedics and Related Research|March 30, 2016
What Is the Role of Allogeneic Cortical Strut Grafts in the Treatment of Fibrous Dysplasia of the Proximal Femur?Bastiaan C J Majoor, Marleen J M Peeters-Boef, Michiel A J van de Sande, et al.
Lung|June 29, 2013
Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal studyMyrthe P P van Herk-Sukel, Sumitra Shantakumar, Fernie J A Penning-van Beest, et al.
Chest|October 18, 2019
Corticosteroid Withdrawal-Induced Loss of Control in Mild to Moderate Asthma Is Independent of Classic Granulocyte ActivationLinsey E S de Groot, Marianne A van de Pol, Niki Fens, et al.
Orphanet Journal of Rare Diseases|April 29, 2017
Determinants of impaired quality of life in patients with fibrous dysplasiaBas C J Majoor, Cornelie D Andela, Jens Bruggemann, et al.
Allergy|December 28, 2020
Transcriptional changes in alveolar macrophages from adults with asthma after allergen challengeJack Yang, Brendon P Scicluna, Tjitske S R van Engelen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 29, 2015
Loss of asthma control and activation of coagulation and fibrinolysisM M S Sneeboer, N Fens, M A van de Pol, et al.
Expert Opinion on Drug Safety|May 25, 2021
The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heartA M Akkerman-Nijland, J E Möhlmann, O W Akkerman, et al.
Therapeutic Drug Monitoring|November 9, 2020
Quantitative Method for the Analysis of Ivacaftor, Hydroxymethyl Ivacaftor, Ivacaftor Carboxylate, Lumacaftor, and Tezacaftor in Plasma and Sputum Using Liquid Chromatography With Tandem Mass Spectrometry and Its Clinical ApplicabilitySteffie E M Vonk, Marloes van der Meer-Vos, Lieuwe D J Bos, et al.
Calcified Tissue International|December 2, 2021
Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's SyndromeM Hagelstein-Rotman, N M Appelman-Dijkstra, A M Boyce, et al.
Pageof 6